Table 4.
High-risk HPV exposed group | High-risk HPV Non-exposed group | P-value | |
---|---|---|---|
OR (95%CI) | |||
MTX | 6(17) | 11(107) | 0.005 |
4.76 (1.471-15.402) | |||
more than 2 immunosuppressants | 8(17) | 21(107) | 0.013 |
3.64 (1.255-10.562) | |||
thiopurine | 12(17) | 54(107) | 0.106 |
High-risk HPV exposed group | High-risk HPV Non-exposed group | P-value | |
---|---|---|---|
OR (95%CI) | |||
MTX | 6(17) | 11(107) | 0.005 |
4.76 (1.471-15.402) | |||
more than 2 immunosuppressants | 8(17) | 21(107) | 0.013 |
3.64 (1.255-10.562) | |||
thiopurine | 12(17) | 54(107) | 0.106 |